Meridian Bioscience Launches Two New TRU(TM) Brand Rapid Tests For The Detection Of Epstein-Barr Virus

Meridian Bioscience, Inc. (NASDAQ: VIVO) announced that it has launched two new rapid tests for Epstein-Barr Virus (EBV): TRU EBV-M? and TRU EBV-G?. The TRU EBV tests are the first rapid tests on the market which employ recombinant antigen technology to detect IgM and IgG antibodies specific to EBV.

More: continued here

Filed under: Infectious Diseases / Bacteria / Viruses on April 11th, 2008